About Us Ikerian AG (formerly RetinAI, now part of Essilor Luxottica) is a fast-growing software company headquartered in Bern, Switzerland. Our mission is to enable the right decisions sooner in healthcare, through transformative AI & data management
Are you looking for. an exciting professional challenge? We are one of the leading European contract manufacturers in the pharmaceutical, biotech and healthcare sectors, with some 2,300 employees in Germany, France, Finland, UK and Norway. For
PhD Candidate in Clinical AI, Data Privacy and Large Language Models Im a true BFH fan, says Anna Knutti . The whole package is just great. What I really like is how my remit keeps changing. This helps
machineMD is a Bern-based medical device company pioneering automated neurodiagnostics through our flagship neo s device and oculometrics software. Were growing our R&D team and adding a Senior Biomedical R&D Engineer – Oculometrics & Neurodiagnostic Paradigms
About Us Ikerian AG (formerly RetinAI Medical) is a fast-growing medical device software company headquartered in Bern, Switzerland. Our mission is to enable the right decisions sooner in healthcare, through transformative AI & data management solutions for
The Amazon Web Services Healthcare and Life Sciences (HCLS) Professional Services (ProServe) team is seeking an experienced Clinical ProServe Cloud Architect (PCA) to join our team in Europe. In this role, youll work directly with pharmaceutical and
About UsIkerian AG (formerly RetinAI, now part of Essilor Luxottica) is a fast-growing software company headquartered in Bern, Switzerland. Our mission is to enable the right decisions sooner in healthcare, through transformative AI & data management solutions
Ikerian AG in Bern, Switzerland, part of EssilorLuxottica, seeks a Head of Commercial to drive global revenue growth across clinical SaaS, research collaborations, and data-driven solutions. You will bridge innovation with demand, optimize pricing, and institutionalize modern sales
Chief Scientific Officer (CSO) – 80–100% – Member of the Executive BoardThe Swiss Cancer Institute is the national network for clinical cancer research in Switzerland. Since 1965, we have been committed to improving cancer treatment for the